Table 3

Mean (SD) walking mobility outcomes at weeks 1, 12, 24 and 36 in exercise plus SCT group (SCT) and exercise plus education control group (CON)

Outcome variableWeek 1Week 12Week 24Week 36
SCTCONSCTCONSCTCONSCTCON
Intention-to-treat analysis
6MWT445.2
(68.8)
482.0
(72.0)
527.4
(91.1)
547.1
(96.0)
492.8
(73.5)
504.9
(76.9)
515.8
(91.0)
528.0
(93.2)
TUG7.06
(1.61)
6.51
(1.36)
6.27
(1.45)
5.81
(1.08)
6.23
(1.26)
6.00
(0.98)
5.93
(1.33)
5.96
(1.20)
MSWS-1238.0
(28.0)
33.3
(24.8)
29.6
(22.2)
30.8
(21.3)
31.9
(22.1)
26.3
(21.5)
32.6
(23.4)
27.9
(21.9)
Secondary analysis
6MWT434.6
(65.2)
474.4
(69.6)
524.2
(96.7)
535.2
(88.0)
496.2
(73.7)
504.9
(76.9)
515.8
(91.0)
528.0
(93.2)
TUG7.08
(1.73)
6.65
(1.36)
6.43
(1.46)
5.87
(1.13)
6.30
(1.25)
6.00
(0.98)
5.93
(1.33)
5.96
(1.20)
MSWS-1238.2
(26.7)
31.9
(22.6)
29.7
(22.6)
32.6
(21.0)
31.9
(22.1)
26.3
(21.5)
32.6
(23.4)
27.0
(21.8)
  • MSWS-12,¬†Multiple Sclerosis¬†Walking Scale-12;¬†6MWT, Six-Minute Walk Test; TUG, Timed Up and Go.